{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:20:01Z","timestamp":1794874801480,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.mycmed.2026.101641","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:19:38Z","timestamp":1785338378000},"page":"101641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is there a role for rezafungin in intra-abdominal Candida spp. infections? A case series and literature review"],"prefix":"10.1016","volume":"36","author":[{"given":"Lucia","family":"Diella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-7118","authenticated-orcid":false,"given":"Davide Fiore","family":"Bavaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7810-7959","authenticated-orcid":false,"given":"Pietro","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Roperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Verduci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Mondatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bussini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Vanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Fusilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Casari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Del Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2026.101641_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/jof11050362","article-title":"Management of intra-abdominal candidiasis in intensive care setting: a narrative review","volume":"11","author":"Pais","year":"2025","journal-title":"J. Fungi"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101641_bib0002","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/14787210.2023.2240956","article-title":"Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin","volume":"21","author":"Oliva","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101641_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40635-023-00552-0","article-title":"Reappraisal of intra-abdominal candidiasis: insights from peritoneal fluid analysis","volume":"11","author":"Novy","year":"2023","journal-title":"Intensive Care Med Exp"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101641_bib0004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40121-021-00585-6","article-title":"Risk factors for intra-abdominal candidiasis in intensive care units: results from EUCANDICU study","volume":"11","author":"Bassetti","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.mycmed.2026.101641_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome ofinvasive candidiasis in intensive care units (ICUs) in Europe: results ofthe EUCANDICU project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.mycmed.2026.101641_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01009-17","article-title":"Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2026.101641_bib0007","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13054-024-05117-5","article-title":"Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials","volume":"28","author":"Honor\u00e9","year":"2024","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101641_bib0008","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101641_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106435","article-title":"Rezafungin in special populations with candidaemia and\/or invasive candidiasis","volume":"90","author":"Cornely","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.mycmed.2026.101641_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.108046","article-title":"Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: a retrospective multicenter cohort study","volume":"160","author":"Bavaro","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101641_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153247","article-title":"Intra-Abdominal candidiasis: the importance of early source control and antifungal treatment","volume":"11","author":"Vergidis","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101641_bib0012","article-title":"Review of the novel Echinocandin antifungal rezafungin: animal studies and clinical data","volume":"6","author":"Zhao","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101641_bib0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17425255.2024.2424899","article-title":"Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation","volume":"21","author":"Bassetti","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101641_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01339-23","article-title":"Absence of clinically meaningful drug-drug interactions with rezafungin: outcome of investigations","volume":"11","author":"Flanagan","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101641_bib0015","article-title":"Rezafungin-mechanisms of action, susceptibility and resistance: similarities and differences with the other echinocandins","volume":"6","author":"Garcia-Effron","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"11","key":"10.1016\/j.mycmed.2026.101641_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00842-21","article-title":"Population pharmacokinetics of rezafungin in patients with fungal infections","volume":"65","author":"Rubino","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101641_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01992-20","article-title":"Efficacy of Rezafungin in prophylactic mouse models of invasive candidiasis, aspergillosis, and pneumocystis pneumonia","volume":"65","author":"Miesel","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101641_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106435","article-title":"Rezafungin in special populations with candidaemia and\/or invasive candidiasis","volume":"90","author":"Cornely","year":"2025","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.mycmed.2026.101641_bib0019","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1093\/cid\/ciaa1380","article-title":"The STRIVE trial investigators, rezafungin versus Caspofungin in a phase 2, randomized, double-blind study for the treatment of candidemia and invasive candidiasis: the STRIVE trial","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101641_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(23)00551-0","article-title":"Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials","volume":"24","author":"Thompson","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101641_bib0021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jac\/dkae415","article-title":"The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics","volume":"80","author":"Andes","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.mycmed.2026.101641_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.546","article-title":"Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: insights on the PK\/PD pharmacometrics of rezafungin efficacy","volume":"7","author":"Miesel","year":"2019","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101641_bib0023","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cmi.2024.11.029","article-title":"Clinical and mycological outcomes of candidaemia and\/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin","volume":"31","author":"Soriano","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2026.101641_bib0024","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT07093203#study-overview."},{"issue":"10370","key":"10.1016\/j.mycmed.2026.101641_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101641_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70163","article-title":"Rezafungin for salvage or consolidation therapy of invasive fungal disease: experience in real-world clinical practice","volume":"69","author":"Bo\u00e1n","year":"2026","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101641_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70114","article-title":"Rezafungin utilisation in real life-FungiScope results from Europe and the United States","volume":"68","author":"Reinhold","year":"2025","journal-title":"Mycoses"},{"issue":"18","key":"10.1016\/j.mycmed.2026.101641_bib0028","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/17460913.2025.2604475","article-title":"Real-world experience with rezafungin for the treatment of biofilm-forming Candida infections","volume":"20","author":"Albanell-Fern\u00e1ndez","year":"2025","journal-title":"Future Microbiol"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523326000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523326000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:14:29Z","timestamp":1794874469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523326000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1156523326000429"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2026.101641","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a role for rezafungin in intra-abdominal Candida spp. infections? A case series and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2026.101641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SFMM. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101641"}}